Featured Articles : Hepatology

Secondary Logo

Journal Logo

A3907, a systemic ASBT inhibitor, improves cholestasis in mice by multiorgan activity and shows translational relevance to humans

Caballero-Camino, Francisco J.; Rodrigues, Pedro M.; Wångsell, Fredrik; More

Hepatology. 78(3):709-726, September 2023.

Phase 2 trial of bintrafusp alfa as second-line therapy for patients with locally advanced/metastatic biliary tract cancers

Yoo, Changhoon; Javle, Milind M.; Verdaguer Mata, Helena; More

Hepatology. 78(3):758-770, September 2023.

The global fatty liver disease Sustainable Development Goal country score for 195 countries and territories

Lazarus, Jeffrey V.; Han, Hannah; Mark, Henry E.; More

Hepatology. 78(3):911-928, September 2023.